Cargando…
Substandard and counterfeit medicines: a systematic review of the literature
OBJECTIVE: To explore the evidence available of poor-quality (counterfeit and substandard) medicines in the literature. DESIGN: Systematic review. DATA SOURCES: Databases used were EMBASE, MEDLINE, PubMed and the International Pharmaceutical Abstracts, including articles published till January 2013....
Autores principales: | Almuzaini, Tariq, Choonara, Imti, Sammons, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752049/ https://www.ncbi.nlm.nih.gov/pubmed/23955188 http://dx.doi.org/10.1136/bmjopen-2013-002923 |
Ejemplares similares
-
Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013) -
Substandard medicines: a greater problem than counterfeit medicines?
por: Sammons, Helen M, et al.
Publicado: (2017) -
Quality of medicines in Canada: a retrospective review of risk communication documents (2005–2013)
por: Almuzaini, Tariq, et al.
Publicado: (2014) -
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021) -
Counterfeit medicines in Peru: a retrospective review (1997–2014)
por: Medina, Edwin, et al.
Publicado: (2016)